Hyperleptinaemia positively correlated with metabolic syndrome in hemodialysis patients

2011 ◽  
Vol 22 (6) ◽  
pp. e105-e109 ◽  
Author(s):  
Jen-Pi Tsai ◽  
Chen-Chi Tsai ◽  
Hsiang-Man Liu ◽  
Chung-Jen Lee ◽  
Hung-Hsiang Liou ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Hemodialysis Patients

scholarly journals Associations of Cardiovascular and All-Cause Mortality with Metabolic Syndrome in Hemodialysis Patients: A Prospective Single-Center Study

Medicina ◽  
2019 ◽  
Vol 55 (10) ◽  
pp. 694
Author(s):  
Zorica Dimitrijevic ◽  
Andriana Jovanovic ◽  
Mina Cvetkovic ◽  
Tamara Vrecic ◽  
Emina Kostic ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Metabolic Disorders ◽  
Cardiometabolic Risk ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Single Center Study ◽  
All Cause Mortality

Background and objectives: Metabolic syndrome (MetS) is a cluster of risk factors, such as abdominal obesity, insulin resistance, dyslipidemia and hypertension, that together increase the risk of cardiovascular disease. Chronic hemodialysis (HD) patients have multiple comorbidities and many metabolic disorders, causing the frequent occurrence of metabolic syndrome. The goal of this study was to assess the prevalence of MetS in HD patients, and its association with all-cause and cardiovascular (CV) mortality. Patients and methods: A total of 138 HD patients were included in this prospective study. We analyzed demographic, anthropometric and biochemical data. Outcome measures were all-cause and CV mortality during the three-year follow-up. Results: MetS was diagnosed in 57.24% of enrolled patients. During the 36 months of follow-up, 33 patients died. MetS patients showed a significantly higher mortality rate than non-MetS (30.4% versus 16.36%, p < 0.001). The association of different MetS components with cardiovascular mortality reached significance when a minimum of three components were present (1.81 (95% confidence interval CI = 1.21–2.33)), with a grouped increase in effect size for subjects with four or five MetS components. Subjects with MetS exhibited nearly twice as high risk for all-cause (hazard ratio HR = 1.99 (95%CI) = 1.42–2.97) and 2.5 times for CV (HR = 2.51 (95%CI) = 1.25–3.83) mortality compared with those without MetS, after adjustment for age, gender, and cardiovascular disease. Conclusions: The study demonstrates that MetS is widespread in HD patients. In future, the focus must be on an active screening approach, and treatment of cardiometabolic risk factors, aiming to reduce mortality.

Does Metabolic Syndrome Have an Impact on the Quality of Life and Mood of Hemodialysis Patients?

2009 ◽  
Vol 19 (5) ◽  
pp. 365-371 ◽  
Author(s):  
Baris Afsar ◽  
Rengin Elsurer ◽  
Siren Sezer ◽  
Nurhan F. Ozdemir
Keyword(s):  
Quality Of Life ◽  
Metabolic Syndrome ◽  
Hemodialysis Patients

W08-P-025 Interleukin-6 and TNF-alpha in hemodialysis patients: Association with obesity and metabolic syndrome

2005 ◽  
Vol 6 (1) ◽  
pp. 36
Author(s):  
Z. Rasic-Milutinovic ◽  
G. Perunicic ◽  
S. Pljesa ◽  
M. Ilic ◽  
S. Stankovic ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Interleukin 6 ◽  
Hemodialysis Patients ◽  
Tnf Alpha

scholarly journals Assessment of Relationship Between Serum Vitamin D Levels and Metabolic Syndrome Components in Hemodialysis Patients

2021 ◽  
Vol 28 (1) ◽  
pp. E202113
Author(s):  
Sevil Karahan Yılmaz ◽  
Cuma Mertoğlu ◽  
Aylin Ayaz
Keyword(s):  
Metabolic Syndrome ◽  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Serum Vitamin ◽  
Vitamin D Insufficiency ◽  
Hemodialysis Patients ◽  
Hydroxyvitamin D ◽  
Serum Vitamin D ◽  
Vitamin D Levels ◽  
25 Oh Vitamin D

Aim: This study is aimed to evaluate the relationship between serum vitamin D levels and metabolic syndrome in hemodialysis patients. Materials and Methods: This study was conducted with participation of 80 patients undergoing hemodialysis for more than 6 months three times a week, aged > 18 years. Their height, dry weight, waist circumference were measured. Biochemical parameters such as serum 25-hydroxyvitamin D, lipid profile, and fasting blood glucose were analyzed. Metabolic syndrome was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria. Severe vitamin D deficiency, 25 (OH) vitamin D < 5 ng/ml; mild vitamin D deficiency, 25 (OH) vitamin D 5-15 ng/ml; vitamin D insufficiency, 25 (OH) vitamin D 16-30 ng/ml, and vitamin D sufficiency, 25 (OH) vitamin D > 30 ng/ml were categorized. Statistical analysis of the data was performed with the use of SPSS version 21.0. Results: 48.4% of hemodialysis patients were identified to have metabolic syndrome. According to the serum levels of vitamin D; 35.0% of patients had severe vitamin D deficiency, 37.4% of patients had mild vitamin D deficiency, 18.8% of patients had vitamin D insufficiency and 8.8% of patients had vitamin D sufficiency (> 30 ng/ml). Vitamin D insufficiency was significantly associated with metabolic syndrome and central obesity. Conclusions: Deficiency/insufficiency is observed in serum 25-hydroxyvitamin D levels in hemodialysis patients. Vitamin D insufficiency is associated with metabolic syndrome.

scholarly journals The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical cross-sectional study

PLoS ONE ◽  
2018 ◽  
Vol 13 (3) ◽  
pp. e0193742 ◽  
Author(s):  
Tuyen Van Duong ◽  
Te-Chih Wong ◽  
Hsi-Hsien Chen ◽  
Tzen-Wen Chen ◽  
Tso-Hsiao Chen ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Energy Intake ◽  
Cross Sectional Study ◽  
Hemodialysis Patients ◽  
Dietary Energy ◽  
Sectional Study ◽  
Cross Sectional ◽  
Dietary Energy Intake
Sign in / Sign up

Export Citation Format

Share Document